Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1-Reference-Cited by-同舟云学术

Bladder preservation after neoadjuvant therapy – 2021 IBCN updates part 1

Published:2023-07 Issue:7 Volume:41 Page:307-312
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Hensley Patrick J.^ORCID,Seiler Roland,Herr Harry,Mouw Kent W.,Iyer Gopa,Dyrskjøt Lars,Nawroth Roman,Goebell Peter,Schmitz-Drager Bernd,Todenhofer Tilman,Black Peter C.,Kamat Ashish M.,Williams Stephen B.^ORCID

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference37 articles.

1. The effects of stage divergence on survival after radical cystectomy for urothelial cancer;Hollenbeck;Urol Oncol,2005

2. Absence of tumor on repeat transurethral resection of bladder tumor does not predict final pathologic T0 stage in bladder cancer treated with radical cystectomy;Kukreja;Eur Urol Focus,2018

3. Clinical restaging and tumor sequencing are inaccurate indicators of response to neoadjuvant chemotherapy for muscle-invasive bladder cancer;Becker;Eur Urol,2021

4. Urologic principles define the standards for successful bladder preservation in muscle-invasive bladder cancer;Herr;Eur Urol Focus,2020

5. Novel visualization methods assisted transurethral resection for bladder cancer: an updated survival-based systematic review and meta-analysis;Li;Front Oncol,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From oncogenes to tumor suppressors: The dual role of ncRNAs in fibrosarcoma;Pathology - Research and Practice;2024-06